Dr. Falk Pharma GmbH engages in the development and sale of medication for indications in hematology and gastroenterology in Germany and internationally. The company principally offers prescription drugs that are used in treating inflammatory bowel diseases, cholestatic liver diseases, irritable bowel syndromes, and constipation, as well as for colon cleansing prior to colonoscopies. It also organizes and sponsors medical education events; and offers publications for healthcare professionals, as well as for patients and their families. The company was formerly known as Dr. Falk Arzneimittel GmbH & Co KG and changed its name to Dr. Falk Pharma GmbH in 1989. Dr. Falk Pharma GmbH was founded in 1960 and is headquartered in Freiburg, Germany

Farmabios SpA engages in the manufacture and marketing of active ingredients for pharmaceutical applications. It offers oral cephalosporins, steroids hormones, highly potent substances, multipurpose plant for steroids, sterile cephalosporins, sterile steroids, and antineoplastics. The company was founded in 1961 and is headquartered in Gropello Cairoli, Italy.

AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

AstraZeneca is an innovation-driven biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines that make a meaningful difference in healthcare. AstraZeneca discovers new medicines that are designed to improve the health and quality of life of patients around the world - medicines that are innovative, effective, and which offer added benefits such as reduced side effects or better ways of taking the treatment. AstraZeneca focuses on getting the best from every medicine they make by exploring all the ways it can be used or improved. AstraZeneca was established on April 6, 1999, in Cambridgeshire, United Kingdom.

Chongqing Huapont Pharmaceutical Co. Ltd., part of Huapont Life Sciences Co., Ltd., is a company headquartered in Chongqing, China. The firm manufactures pharmaceutical products.

Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceutica was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.

Glenmark was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company. Over the decades, we have established ourselves as a leading player in the discovery of new molecules both NCEs (New Chemical Entity) and NBEs (New Biological Entity). They have several molecules in various stages of pre-clinical and clinical development and are primarily focused in the areas of Oncology, Respiratory and Dermatology.

Mexichem Fluor SA de CV manufactures hydrofluoric acid. The company is headquartered in San Luis Potosi, Mexico.

Galderma SA develops and markets therapeutic and aesthetic solutions for dermatology. It provides medical dermatological solutions for acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and medical aesthetic and corrective solutions for skin senescence. The company was founded in 1981 and is headquartered in Paris, France.

Chiesi Farmaceutici SpA develops and markets pharmaceutical products. The firm specializes in research, development and production of drugs in respiratory dosage forms, such as metered-dose inhalers and sterile unit dose vials. The company was founded by Giacomo Chiesi in 1935 and is headquartered in Parma, Italy.

Chongqing Huabang Shengkai Pharmaceutical Co., Ltd., established on 2009-08-28, Business scope includes licensed projects:pharmaceutical production;Drug import and export;Pharmaceutical commissioned production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development;Chemical product sales(No licensed chemical products);Manufacturing of basic chemical raw materials(Manufacture of licensed chemicals free of hazardous chemicals).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Research Development Foundation is an American private company that operates as noncommercial research organizations.

Part of Eisai Co., Ltd., EA Pharma Co., Ltd. is a company headquartered in Tokyo, Japan, that manufactures pharmaceutical products for gastrointestinal disease.

Fuyuan Pharmaceutical Co., Ltd., established on 2001-09-03, The business scope includes pharmaceutical preparations,API,Chemical Raw Materials and Chemical Products(Free of Hazardous Chemicals),medical supplements,Sanitary materials and medical supplies,Medical equipment and equipment,Pharmaceutical packaging products,disinfection products,Daily chemical products,Health food production,Sales(Including online sales);Pharmaceutical related product technology development,consult,Achievement transfer;Self-operated or agent of various goods or technology import and export business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Pharmazz, Inc. operates as a pharmaceutical company. It focuses on discovering, acquiring, developing and commercializing therapeutics that target critical care medicine. The company was founded by Anil Gulati and Ajit Chand Srimal in 2010 and is headquartered in Willowbrook, IL.

CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA

Hubei Biomedical Industry Technology Research Institute Co., Ltd., established on 2014-04-25, Business scope includes pharmaceutical,Healthy food,cosmetic,Veterinary Drugs and Intermediates,Technical consultation and technical services for new processes;non-pharmaceutical standard,Sales of self-produced products for reference substances;Own house rental;Import and export,Technology Import and Export,Agent import and export(Goods and technologies prohibited or restricted from import and export by the state are not included).(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Hubei Humanwell Chengtian Pharmaceutical Co., Ltd. is a company that currently produces a wide range of goods, including creams, gels, ointments, lotions, powders, suppositories, and other dosage forms. The principal item is a brand-new kind of antibiotic for topical application to the skin called mupirocin ointment. It is appropriate for many bacterial skin infections and has a considerable commercial potential.

Humanwell Healthcare (Group) Co., Ltd. engages in the research and development, production, and sale of medical products. It focuses on chemical preparations, chemical raw materials, Chinese medicine, and biological agents. Its products include hormone products, natural herbal medicine, central nervous system, skin medicine, Sexual health medicine, animal medicine, traditional Chinese medicine and OTC Zone. The company was founded on March 30, 1993 and is headquartered in Wuhan, China.

Zhejiang Xianju Junye Pharmaceutical Co. Ltd. is a Chinese private company located in Taizhou. The firm specializes in development, production and marketing of steroid hormone APIs and intermediates.